The real-world cost of care to treat hepatocellular carcinoma for patients with hepatitis C cirrhosis is very high, according to findings from a retrospective cohort study.
The real-world cost of care to treat hepatocellular carcinoma for patients with hepatitis C cirrhosis is very high, according to findings from a retrospective cohort study.